HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release

• Nopporn Chutiwitoonchai,

  Affiliations Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan, Japan Foundation for AIDS Prevention, Chiyoda-ku, Tokyo, Japan

  ⨯
• Lowela Siarot,

  Affiliations Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan

  ⨯
• Eri Takeda,

  Affiliation Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  ⨯
• Tatsuo Shioda,

  Affiliation Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan

  ⨯
• Motoki Ueda,

  Affiliation Nano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan

  ⨯
• Yoko Aida

  * E-mail: aida@riken.jp

  Affiliation Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan

  ⨯